Related Experiment Video
Updated: May 4, 2026
08:25
An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
Published on: April 27, 2021
2.3K
Luteolin inhibits mast cell-mediated allergic inflammation
S K Kritas1, A Saggini2, G Varvara3
1Department of Microbiology and Infectious Diseases, School of Veterinary Medicine, Aristotle University of Thessaloniki, Macedonia, Greece.
Journal of Biological Regulators and Homeostatic Agents
|January 3, 2014
Summary
Luteolin, a flavonoid, impacts mast cell activation by regulating inflammatory responses. This study investigates its potential in managing mast cell-mediated allergic diseases.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Mast cells are key immune cells involved in allergic reactions and host defense.
- Activation of mast cells, via FcεRI cross-linking, triggers the release of inflammatory mediators.
- Luteolin, a flavonoid, possesses antioxidant properties and modulates inflammatory processes.
Discussion:
- This research explores luteolin's effect on mast cell activation pathways.
- Investigates how luteolin influences the cascade of intracellular reactions following mast cell stimulation.
- Examines luteolin's potential role in regulating mast cell-mediated inflammatory diseases and allergies.
Key Insights:
- Luteolin demonstrates a regulatory effect on mast cell activation.
- The study elucidates the impact of luteolin on mediator release from activated mast cells.
- Findings suggest luteolin's therapeutic potential in allergic conditions.
Outlook:
- Further research into luteolin's precise molecular mechanisms in mast cells is warranted.
- Exploring luteolin's efficacy in preclinical models of allergy and inflammation.
- Investigating the synergistic effects of luteolin with other anti-allergy compounds.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
01:28Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
01:38Inflammation
46.6K
Overview
46.6K
01:30Allergic Reactions: Anaphylaxis
280
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
280